Group decision-making

Eve Sleep plc: Result of AGM

Retrieved on: 
Wednesday, May 26, 2021
Corporate law, Elections, Parliamentary procedure, Voting, Proxy, Corporate governance, Articles, Shareholders, Corporations, Group decision-making, Proxy voting

Proxy appointments which gave discretion to the Chairman of the Meeting have been included in the "For" total for the appropriate resolution.

Key Points: 
  • Proxy appointments which gave discretion to the Chairman of the Meeting have been included in the "For" total for the appropriate resolution.
  • Votes "For" and "Against" any resolution are expressed as a percentage (rounded to two decimal places) of votes validly cast for that resolution.
  • A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
  • The full text of the resolutions passed at the Meeting can be found in the Notice of Meeting which is available on the Company's website at: https://investor.evesleep.co.uk/
    These poll results (inclusive of proxy results lodged before the Meeting) will be available shortly on the Company's website at: https://investor.evesleep.co.uk/

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Wednesday, May 26, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Wednesday, May 26, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Retrieved on: 
Tuesday, May 25, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc

Retrieved on: 
Tuesday, May 25, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Strongbridge Biopharma plc

Retrieved on: 
Tuesday, May 25, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Tuesday, May 25, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Tuesday, May 25, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

NOXXON Announces Convocation of Its Hybrid 2021 Annual General Meeting of Shareholders

Retrieved on: 
Tuesday, May 25, 2021
Biotechnology, Other Health, Health, Pharmaceutical, Oncology, Corporate governance, Corporate law, Democracy, Direct democracy, Power of attorney, Proxy voting, Proxy, Articles, Group decision-making, Political philosophy

Shareholders do not need to be present to cast their vote at the AGM on June 24, 2021.

Key Points: 
  • Shareholders do not need to be present to cast their vote at the AGM on June 24, 2021.
  • Further details on proxy voting are given in the Attendance Notice for this AGM available on the companys website ( www.noxxon.com ).
  • The company acknowledges that constraints caused by the COVID-19 pandemic restrict the physical presence of its shareholders at the AGM and thus, to ask questions at the meeting.
  • These documents are also available at the company's offices at Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany, for shareholders and persons entitled to attend the meeting who, upon request, will receive a copy free of charge.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Monday, May 24, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Regulation S-K, Group decision-making

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO